Literature DB >> 15165114

Detection of telomerase activity and the expression of telomerase subunits in the patients with acute myelogenous leukaemia.

Yirong Li1, Jianming Wu, Lin Wang, Fenghua Chen, Lihua Hu.   

Abstract

Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the up-regulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165114     DOI: 10.1007/bf02830704

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Telomere-related components are coordinately synthesized during human T-lymphocyte activation.

Authors:  B A Kosciolek; P T Rowley
Journal:  Leuk Res       Date:  1999-12       Impact factor: 3.156

2.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  Telomerase primer specificity and chromosome healing.

Authors:  L A Harrington; C W Greider
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

Review 4.  Telomerase, cell immortality, and cancer.

Authors:  C B Harley; N W Kim; K R Prowse; S L Weinrich; K S Hirsch; M D West; S Bacchetti; H W Hirte; C M Counter; C W Greider
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

5.  Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.

Authors:  T Suzuki; Y Suzuki; T Fujioka
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.

Authors:  I Bièche; C Noguès; V Paradis; M Olivi; P Bedossa; R Lidereau; M Vidaud
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

8.  Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia.

Authors:  D Xu; A Gruber; C Peterson; P Pisa
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

9.  Healing of broken human chromosomes by the addition of telomeric repeats.

Authors:  J Flint; C F Craddock; A Villegas; D P Bentley; H J Williams; R Galanello; A Cao; W G Wood; H Ayyub; D R Higgs
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

10.  Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.

Authors:  N Toshikuni; K Nouso; T Higashi; H Nakatsukasa; T Onishi; T Kaneyoshi; Y Kobayashi; K Kariyama; K Yamamoto; T Tsuji
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  1 in total

1.  Effect of survivin regulation of transcription level by p21waf1 overexpression in HepG2 hepatocellular carcinoma cells.

Authors:  Juan Xiong; Lihua Hu; Yirong Li; Lifang Dou; Pengcheng Cai; Zhaoming Tang; Lin Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.